CD96, a new immune checkpoint, correlates with immune profile and clinical outcome of glioma
Abstract CD96 is a promising candidate for immunotherapy. However, its role and importance in glioma remains unknown. We thus aimed to genetically and clinically characterize CD96 expression in gliomas. For this, we extracted RNA-seq data of 699 glioma samples from the TCGA dataset and validated the...
Saved in:
Main Authors: | , , , , , , , |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/cc2f23111ef7425386ea78d03e4895fc |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!